Literature DB >> 15361064

The disintegrin domain of ADAM9: a ligand for multiple beta1 renal integrins.

Rajeev M Mahimkar1, Orvin Visaya, Allan S Pollock, David H Lovett.   

Abstract

Renal tubular epithelial cells in all nephron segments express a distinct member of the metalloprotease-disintegrin family, ADAM9 (a disintegrin and metalloprotease 9), in a punctate basolateral distribution co-localized to the beta1 integrin chain [Mahimkar, Baricos, Visaya, Pollock and Lovett (2000) J. Am. Soc. Nephrol. 11, 595-603]. Discrete segments of the nephron express several defined beta1 integrins, suggesting that ADAM9 interacts with multiple renal integrins and thereby regulates epithelial cell-matrix interactions. Intact ADAM9 and a series of deletion constructs sequentially lacking the metalloprotease domain and the disintegrin domain were assembled as chimaeras with a C-terminal GFP (green fluorescent protein) tag. Stable expression of the ADAM9/GFP protein on the surface of HEK-293 cells (human embryonic kidney 293 cells) significantly decreased adhesion to types I and IV collagen, vitronectin and laminin, but had little effect on adhesion to fibronectin. Expression of the disintegrin/cysteine-rich/GFP construct yielded a similar, but more marked pattern of decreased adhesion. Expression of the cysteine-rich/GFP construct had no effect on adhesion, indicating that the disintegrin domain was responsible for the competitive inhibition of cell-matrix binding. To define the specific renal tubular beta1 integrins interacting with the ADAM9 disintegrin domain, a recombinant GST (glutathione S-transferase)-disintegrin protein was used as a substrate in adhesion assays in the presence or absence of specific integrin-blocking antibodies. Inclusion of antibodies to alpha1, alpha3, alpha6, alphav and beta1 blocked adhesion of HEK-293 cells to GST-disintegrin protein. Immobilized GST-disintegrin domain perfused with renal cortical lysates specifically recovered the alpha3, alpha6, alphav and beta1 integrin chains by Western analysis. It is concluded that ADAM9 is a polyvalent ligand, through its disintegrin domain, for multiple renal integrins of the beta1 class.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15361064      PMCID: PMC1134717          DOI: 10.1042/BJ20041133

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  25 in total

1.  Identification, cellular distribution and potential function of the metalloprotease-disintegrin MDC9 in the kidney.

Authors:  Rajeev M Mahimkar; William H Baricos; Orvin Visaya; Allan S Pollock; David H Lovett
Journal:  J Am Soc Nephrol       Date:  2000-04       Impact factor: 10.121

2.  RGD-independent binding of integrin alpha9beta1 to the ADAM-12 and -15 disintegrin domains mediates cell-cell interaction.

Authors:  K Eto; W Puzon-McLaughlin; D Sheppard; A Sehara-Fujisawa; X P Zhang; Y Takada
Journal:  J Biol Chem       Date:  2000-11-10       Impact factor: 5.157

3.  Functional classification of ADAMs based on a conserved motif for binding to integrin alpha 9beta 1: implications for sperm-egg binding and other cell interactions.

Authors:  Koji Eto; Clotilde Huet; Takehiko Tarui; Sergey Kupriyanov; Hai-Zhen Liu; Wilma Puzon-McLaughlin; Xi-Ping Zhang; Dean Sheppard; Eva Engvall; Yoshikazu Takada
Journal:  J Biol Chem       Date:  2002-03-06       Impact factor: 5.157

4.  Tumor necrosis factor-alpha converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability.

Authors:  Susan Wohler Sunnarborg; C Leann Hinkle; Mary Stevenson; William E Russell; Christina S Raska; Jacques J Peschon; Beverly J Castner; Mary J Gerhart; Raymond J Paxton; Roy A Black; David C Lee
Journal:  J Biol Chem       Date:  2002-01-31       Impact factor: 5.157

5.  MDC-9 (ADAM-9/Meltrin gamma) functions as an adhesion molecule by binding the alpha(v)beta(5) integrin.

Authors:  M Zhou; R Graham; G Russell; P I Croucher
Journal:  Biochem Biophys Res Commun       Date:  2001-01-19       Impact factor: 3.575

6.  The lymphocyte metalloprotease MDC-L (ADAM 28) is a ligand for the integrin alpha4beta1.

Authors:  Lance C Bridges; Patricia H Tani; Krista R Hanson; Charles M Roberts; Matthew B Judkins; Ron D Bowditch
Journal:  J Biol Chem       Date:  2001-11-27       Impact factor: 5.157

Review 7.  Tumor necrosis factor-alpha converting enzyme.

Authors:  Roy A Black
Journal:  Int J Biochem Cell Biol       Date:  2002-01       Impact factor: 5.085

8.  Shedding light on sheddases: role in growth and development.

Authors:  Farrah Kheradmand; Zena Werb
Journal:  Bioessays       Date:  2002-01       Impact factor: 4.345

9.  The integrin beta 1 subunit associates with the vitronectin receptor alpha v subunit to form a novel vitronectin receptor in a human embryonic kidney cell line.

Authors:  S C Bodary; J W McLean
Journal:  J Biol Chem       Date:  1990-04-15       Impact factor: 5.157

10.  Meltrin gamma(ADAM-9) mediates cellular adhesion through alpha(6)beta(1 )integrin, leading to a marked induction of fibroblast cell motility.

Authors:  D Nath; P M Slocombe; A Webster; P E Stephens; A J Docherty; G Murphy
Journal:  J Cell Sci       Date:  2000-06       Impact factor: 5.285

View more
  23 in total

1.  Secreted and membrane-bound isoforms of protease ADAM9 have opposing effects on breast cancer cell migration.

Authors:  Jessica L Fry; Alex Toker
Journal:  Cancer Res       Date:  2010-08-24       Impact factor: 12.701

2.  The emerging role of matrix metalloproteases of the ADAM family in male germ cell apoptosis.

Authors:  Ricardo D Moreno; Paulina Urriola-Muñoz; Raúl Lagos-Cabré
Journal:  Spermatogenesis       Date:  2011-07-01

Review 3.  Key metalloproteinase-mediated pathways in the kidney.

Authors:  Tammo Ostendorf; Andreas Ludwig; Justyna Wozniak; Jürgen Floege
Journal:  Nat Rev Nephrol       Date:  2021-04-20       Impact factor: 28.314

4.  ADAM9 is a novel product of polymorphonuclear neutrophils: regulation of expression and contributions to extracellular matrix protein degradation during acute lung injury.

Authors:  Robin Roychaudhuri; Anja H Hergrueter; Francesca Polverino; Maria E Laucho-Contreras; Kushagra Gupta; Niels Borregaard; Caroline A Owen
Journal:  J Immunol       Date:  2014-07-25       Impact factor: 5.422

5.  The mojastin mutant Moj-DM induces apoptosis of the human melanoma SK-Mel-28, but not the mutant Moj-NN nor the non-mutated recombinant Moj-WN.

Authors:  Agustin I Seoane; Victoria L Tran; Elda E Sanchez; Stephanie A White; Jason L Choi; Brandon Gaytán; Natalie Chavez; Steven R Reyes; Carla J Ramos; Luan H Tran; Sara E Lucena; Maria Sugarek; John C Perez; Stephanie A Mandal; Shervin Ghorab; Alexis Rodriguez-Acosta; Branden K Fung; Julio G Soto
Journal:  Toxicon       Date:  2010-04-14       Impact factor: 3.033

6.  Recombinant rubistatin (r-Rub), an MVD disintegrin, inhibits cell migration and proliferation, and is a strong apoptotic inducer of the human melanoma cell line SK-Mel-28.

Authors:  Clayton M Carey; Raymund Bueno; Daniel A Gutierrez; Christopher Petro; Sara E Lucena; Elda E Sanchez; Julio G Soto
Journal:  Toxicon       Date:  2011-12-13       Impact factor: 3.033

7.  Functional analysis of a recombinant PIII-SVMP, GST-acocostatin; an apoptotic inducer of HUVEC and HeLa, but not SK-Mel-28 cells.

Authors:  Takele Teklemariam; Agustin I Seoane; Carla J Ramos; Elda E Sanchez; Sara E Lucena; John C Perez; Stephanie A Mandal; Julio G Soto
Journal:  Toxicon       Date:  2011-01-19       Impact factor: 3.033

8.  The ADAM9/UBN2/AKR1C3 axis promotes resistance to androgen-deprivation in prostate cancer.

Authors:  Trang Thi-Huynh Le; Chia-Ling Hsieh; I-Hsuan Lin; Cheng-Ying Chu; Anh Duy Do; Seu-Hwa Chen; Katsumi Shigemura; Koichi Kitagawa; Masato Fujisawa; Ming-Che Liu; Kuan-Chou Chen; Shian-Ying Sung
Journal:  Am J Cancer Res       Date:  2022-01-15       Impact factor: 6.166

9.  ADAM9 enhances Th17 cell differentiation and autoimmunity by activating TGF-β1.

Authors:  Masataka Umeda; Nobuya Yoshida; Ryo Hisada; Catalina Burbano; Seo Yeon K Orite; Michihito Kono; Vasileios C Kyttaris; Suzanne Krishfield; Caroline A Owen; George C Tsokos
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-04       Impact factor: 11.205

10.  Loss of the metalloprotease ADAM9 leads to cone-rod dystrophy in humans and retinal degeneration in mice.

Authors:  David A Parry; Carmel Toomes; Lina Bida; Michael Danciger; Katherine V Towns; Martin McKibbin; Samuel G Jacobson; Clare V Logan; Manir Ali; Jacquelyn Bond; Rebecca Chance; Steven Swendeman; Lauren L Daniele; Kelly Springell; Matthew Adams; Colin A Johnson; Adam P Booth; Hussain Jafri; Yasmin Rashid; Eyal Banin; Tim M Strom; Debora B Farber; Dror Sharon; Carl P Blobel; Edward N Pugh; Eric A Pierce; Chris F Inglehearn
Journal:  Am J Hum Genet       Date:  2009-04-30       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.